EPISODE · Oct 3, 2024 · 30 MIN
Why Cell and Gene Therapies Cost So Much – And What Can Be Done
from Is Business Broken? · host Questrom School of Business
Last week's episode introduced the promises and challenges brought forth by Cell and Gene Therapies. Today's show dives deeper into this topic with BU Questrom Professor Rena Conti, an expert on the financing and regulation of the biopharmaceutical market. She and host Curt Nickisch discuss why these treatments are so expensive, challenges for insurance companies, and potential solutions to ensure fair access. Learn more about your ad choices. Visit podcastchoices.com/adchoices
What this episode covers
Last week's episode introduced the promises and challenges brought forth by Cell and Gene Therapies. Today's show dives deeper into this topic with BU Questrom Professor Rena Conti, an expert on the financing and regulation of the biopharmaceutical market. She and host Curt Nickisch discuss why these treatments are so expensive, challenges for insurance companies, and potential solutions to ensure fair access. Learn more about your ad choices. Visit podcastchoices.com/adchoices
NOW PLAYING
Why Cell and Gene Therapies Cost So Much – And What Can Be Done
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m